• Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Psychedelic Invest

Investing in Psychedelics

  • Home
  • News
    • Analysis
    • Interviews
    • Press
  • Index
  • Resources
    • Psychedelic Investors
    • Psychedelic Stocks
    • Psychedelic Law Firms
    • Events
    • Jobs
  • Invest

New Wave: Enters into Partnership with the University of West Indies, Mona, Jamaica for Medicinal Drug Discovery

Quick Take:

  • New Wave Holdings Corp. announced it has entered into a joint venture with The University of West Indies, Mona, Jamaica to conduct drug discovery and highlight knowledge of medicinal plants in Jamaica.
  • The purpose of this joint venture/partnership is to develop techniques using local microclimate conditions and local research and commercial advantages to explore various natural products and patent opportunities and to conduct drug discovery.

NEW WAVE HOLDINGS CORP. (the “Company” or “New Wave”) (SPOR) (FWB: 0XM2) (OTC: TRMND) an investment issuer that provides capital and support services, announced it has entered into a joint venture with The University of West Indies, Mona, Jamaica to conduct drug discovery and highlight knowledge of medicinal plants in Jamaica.

The purpose of this joint venture/partnership is to develop techniques using local microclimate conditions and local research and commercial advantages to explore various natural products and patent opportunities and to conduct drug discovery and highlight knowledge of medicinal plants in Jamaica.

The Parties wish to explore opportunities for:

  • research and development of therapeutic drugs and natural health products that are derived from local plants and fungi;
  • commercial activities that can exploit patents, and other research results, concerning local biodiversity;
  • advancing the knowledge of medicinal plants in Jamaica;
  • increase awareness of medicinal plant health

Under the terms of the strategic partnership, New Wave Holdings will provide capital, resources and further support in drug discovery through the University faculty and facilities.

UWI will undertake research and the objective will be to highlight and further develop various components and/or compounds in early drug discovery stages and explore various plants and fungi that show significant results in the following areas: Cancerous properties, Diabetes, Hypercholesterolemia, and Inflammation. Research at the Facility will be led by various scientific professors that specialize in the key areas listed above.

This will be a joint effort between New Wave and UWI brain trust to enhance awareness, innovate new remedies of therapy, and shed light on the medicinal plants and their ultimate consumer health benefits.”

Daniel Fox – CEO New Wave Holdings

Both New Wave and UWI agree to work together under a model where UWI provides research services (personnel and facilities) that are funded by New Wave. The details of these research projects, the funding needed for each, the ownership of the Intellectual Property that results and the licensing terms if any would be negotiated on a project-by-project basis. 

ABOUT NEW WAVE HOLDINGS CORP.

New Wave Holdings Corp. (CSE: SPOR, FWB: 0XM2, OTC: TRMND) is an investment issuer focused on the burgeoning psychedelic sector and support for adaptive and progressive mental health products and therapies. In the psychedelic sector, New Wave will focus on supporting research on active psychedelic compounds, creation of consumer products based on functional mushrooms, and developing an IP portfolio focusing on psilocybin, LSD, MDMA, and ketamine derived treatments for neuropsychiatric diseases. New Wave also contains various health and beauty products within its portfolio of non-psychoactive plants and fungi as it continues to expand its product distribution through vertical integration to provide end to end solutions while capturing a high margin business model.

Investors interested in connecting with New Wave Holdings can learn more about the company and contact the team at http://newwavecorp.com

ABOUT THE UNIVERSITY OF WEST INDIES, MONA, JAMAICA 

The University of the West Indies (UWI) Mona campus offers world class, accredited higher education programmes to Jamaica, the region and the globe. They engage in research and development designed to support the social and economic growth of the Caribbean region, the provision of community service, and the enrichment of the academic experience.

Information relating to The University of the West Indies, Mona, Jamaica, contained in this news release was provided by The University of the West Indies, Mona, Jamaica and/or its agent and has not been independently verified by the Company. The Company does not take responsibility for the accuracy of such information.

The CSE has not in any way passed on the merits of the Acquisition, and neither has approved nor disapproved the contents of this press release. Neither the CSE nor its Market Regulator (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

  • Facebook
  • LinkedIn
  • RSS
  • Twitter

The Next Wave
of BioTech

Subscribe to our newsletter to get the latest business and investing news about the burgeoning psychedelics industry.

Recent Posts

  • Mydecine Innovations Group Files Application to list to the NASDAQ January 27, 2021
  • Field Trip Health Ltd. Announces Opening of Field Trip Health Center in Atlanta, GA, as it Continues Expansion in the US January 26, 2021
  • Champignon Brands’ Canadian Rapid Treatment Center of Excellence Opens First Community-Based Centre in Ottawa to Provide Ketamine Treatment for Adults With Depression January 25, 2021
  • PharmaTher Signs License Agreement for Patented Ketamine Treatment January 22, 2021
  • January, 2021 Update: Psychedelic Index Adds 7 New Companies January 22, 2021
Psychedelics by TradingView

Interview Series

journey colab psychedelics
fluence psychedelic therapy
CaaMTech Davis Wuolle

Footer

Psychedelic Investor

Psychedelics are set to disrupt the multi billion dollar alcohol, tobacco, pharmaceutical, and health & wellness industries.

There is an enormous opportunity for those early investors who are able to look past the historical negative stigma associated with many psychedelics.

Psychedelic Invest is a resource for those looking to invest in the psychedelic industry.

Quick Links

  • About
  • Contact
  • Terms of Use
  • Psychedelic Stock Index
  • Careers

Subscribe

Copyright © 2021 · Psychedelic Invest